X0407 4 2023-03-31 0 0001427570 ReShape Lifesciences Inc. RSLS 0001181166 STANKOVICH THOMAS 1001 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Chief Financial Officer 0 Common Stock, $0.001 par value per share 2023-03-31 4 S 0 109 2.6 D 5982 D Common Stock, $0.001 par value per share 2023-04-30 4 S 0 96 2.36 D 5886 D Common Stock, $0.001 par value per share 2023-05-31 4 S 0 98 2.41 D 5788 D Common Stock, $0.001 par value per share 2023-06-30 4 P 0 17702 1.52 A 23490 D On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.54, inclusive. The reporting person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. /s/ Thomas Stankovich 2023-07-06